Ariosa Diagnostics
Latest round
- Series C
Last raised
- Nov 2011
Total raised
- $68M
Investors
- 3
About Ariosa Diagnostics
Ariosa Diagnostics, Inc.Founded in 2008, Ariosa Diagnostics, Inc. is based in San Jose, US, and focuses on developing innovative prenatal testing solutions. The company was acquired by Roche in December 2014 for an undisclosed amount.Ariosa Diagnostics offers a range of high-quality non-invasive prenatal testing solutions aimed at improving maternal-fetal health. Their flagship product, the Harmony Prenatal Test, utilizes advanced genetic testing technology to provide expectant parents with accurate information about the health of their fetus. Primarily serving healthcare providers and expecting families, the company’s services are designed to enhance clinical decision-making and support positive pregnancy outcomes.The revenue model of Ariosa Diagnostics is anchored in their laboratory testing services, primarily derived from fees charged for their prenatal testing solutions. The pricing structure ensures that healthcare providers can offer accessible testing options to expecting families. Revenue is generated through direct sales to healthcare providers, with many clients opting for multiple tests as part of their prenatal care package.Ariosa Diagnostics is committed to expanding its product offerings, with plans to enhance its testing solutions and introduce new genetic screening technologies. The company aims to penetrate emerging markets in Asia and Europe by 2025, leveraging its existing infrastructure and strategic partnerships to facilitate growth.
Who invested in Ariosa Diagnostics
3 investors across 3 rounds
See all investors in Ariosa Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ariosa Diagnostics
Who invested in Ariosa Diagnostics?
Ariosa Diagnostics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ariosa Diagnostics raised?
Ariosa Diagnostics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ariosa Diagnostics last raise money?
Ariosa Diagnostics's most recent round on record is a Series C, in Nov 2011.
What does Ariosa Diagnostics do?
Ariosa Diagnostics is a biotechnology company.
Where is Ariosa Diagnostics headquartered?
Ariosa Diagnostics is headquartered in San Jose, US.
Which VCs invest in companies like Ariosa Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ariosa Diagnostics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Ariosa Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.